The University of Chicago Header Logo

Connection

Tong-Chuan He to Piperazines

This is a "connection" page, showing publications Tong-Chuan He has written about Piperazines.
Connection Strength

0.413
  1. Tyrosine kinase inhibitor STI-571: the new wonder drug of cancer therapy. Cancer Biol Ther. 2004 Apr; 3(4):393-4.
    View in: PubMed
    Score: 0.213
  2. Tyrosine kinase inhibitor STI-571/Gleevec down-regulates the beta-catenin signaling activity. Cancer Lett. 2003 Apr 25; 193(2):161-70.
    View in: PubMed
    Score: 0.200
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.